瘤消毒病毒疗法作为治疗胰腺癌的新潜在解决方案
Piruz Shadbash1,2, Seyed Masoud Hosseini2, Sahel Abyar1,2
1Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Gastroenterology and hepatology from bed to bench
|July 30, 2025
概括
胰腺癌治疗进展有限. 瘤溶解性病毒疗法为瘤瘤向治疗提供了一个有希望的新途径,有可能改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 病毒学 病毒学
- 分子生物学分子生物学
背景情况:
- 胰腺癌 (PC) 尽管在传统疗法方面取得了进展,但其存活率令人丧.
- 目前的化疗和放射治疗等治疗方法对5年生存率的影响有限.
- 对PC的遗传和分子格局的新兴研究揭示了新的治疗点.
研究的目的:
- 审查瘤病毒作为胰腺癌向治疗的潜力.
- 探索瘤病毒治疗在PC治疗中的机制和应用.
- 评估型病毒疗法作为胰腺癌未来的替代治疗方法.
主要方法:
- 这项研究是对有关瘤病毒和胰腺癌的现有文献的叙事性综述.
- 文献搜索侧重于PC和病毒疗法应用的遗传和分子基础.
- 分析证据,支持结性病毒治疗的疗效和可行性.
主要成果:
- 瘤溶解性病毒疗法已成为胰腺癌的有希望的向治疗方法.
- 对PC的遗传和分子理解支持开发新型向剂.
- 现有证据表明,结性病毒疗法是一种可行的治疗选择.
结论:
- 性病毒疗法在胰腺癌治疗中具有潜在的突破性作用.
- 进一步的研究和型病毒的临床应用可能会对PC结果产生重大影响.
- 这种疗法为管理这种具有挑战性的恶性瘤提供了未来的替代方案.
相关概念视频
Tumor Immunotherapy
662
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
662
Cancer Vaccines
514
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
514
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K


